INR 13.03
(-0.61%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 946.56 Million INR | -47.51% |
2022 | 1.79 Billion INR | 37.54% |
2021 | 1.3 Billion INR | 1.78% |
2020 | 1.28 Billion INR | 10.56% |
2019 | 1.16 Billion INR | 1.79% |
2018 | 1.13 Billion INR | 12.92% |
2017 | 1 Billion INR | -53.4% |
2016 | 2.16 Billion INR | -2.85% |
2015 | 2.22 Billion INR | 86.31% |
2014 | 1.19 Billion INR | -7.09% |
2013 | 1.28 Billion INR | 9.75% |
2012 | 1.17 Billion INR | 0.0% |
2010 | 866.44 Million INR | 21.62% |
2009 | 712.43 Million INR | 13.25% |
2008 | 629.07 Million INR | 2.53% |
2007 | 613.57 Million INR | 26.99% |
2006 | 483.16 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 269.94 Million INR | -29.58% |
2023 Q4 | 283 Million INR | 32.72% |
2023 Q1 | 461.82 Million INR | -2.12% |
2023 Q2 | 488.5 Million INR | 5.78% |
2023 Q3 | 213.23 Million INR | -56.35% |
2023 FY | 942.4 Million INR | -47.51% |
2022 Q3 | 453.79 Million INR | 4.49% |
2022 FY | 1.79 Billion INR | 37.54% |
2022 Q4 | 471.82 Million INR | 3.97% |
2022 Q1 | 436.96 Million INR | 598.81% |
2022 Q2 | 434.3 Million INR | -0.61% |
2021 Q4 | 62.53 Million INR | -86.03% |
2021 Q1 | 386.32 Million INR | 89.08% |
2021 FY | 1.3 Billion INR | 1.78% |
2021 Q2 | 409.1 Million INR | 5.9% |
2021 Q3 | 447.47 Million INR | 9.38% |
2020 Q4 | 204.32 Million INR | -49.6% |
2020 FY | 1.28 Billion INR | 10.56% |
2020 Q2 | 375.09 Million INR | 25.98% |
2020 Q3 | 405.43 Million INR | 8.09% |
2020 Q1 | 297.74 Million INR | 734.34% |
2019 Q2 | 366.27 Million INR | 4.48% |
2019 Q4 | 35.68 Million INR | -91.24% |
2019 Q3 | 407.59 Million INR | 11.28% |
2019 FY | 1.16 Billion INR | 1.79% |
2019 Q1 | 350.58 Million INR | 206.11% |
2018 FY | 1.13 Billion INR | 12.92% |
2018 Q4 | 114.52 Million INR | -66.49% |
2018 Q2 | 364.45 Million INR | -8.7% |
2018 Q1 | 399.19 Million INR | 1049.1% |
2018 Q3 | 341.77 Million INR | -6.22% |
2017 Q3 | 319.13 Million INR | 0.0% |
2017 Q1 | 333.82 Million INR | 125.94% |
2017 FY | 1 Billion INR | -53.4% |
2017 Q4 | 34.74 Million INR | -89.11% |
2016 Q3 | 2.06 Billion INR | 121.43% |
2016 FY | 2.16 Billion INR | -2.85% |
2016 Q1 | 442.79 Million INR | -55.99% |
2016 Q2 | 933.44 Million INR | 110.81% |
2016 Q4 | -1.28 Billion INR | -162.25% |
2015 Q2 | 411.01 Million INR | 13.22% |
2015 Q4 | 1 Billion INR | 127.2% |
2015 FY | 2.22 Billion INR | 86.31% |
2015 Q3 | 442.81 Million INR | 7.74% |
2015 Q1 | 363.03 Million INR | 3483.95% |
2014 Q3 | 554.12 Million INR | 48.88% |
2014 Q2 | 372.18 Million INR | 10.97% |
2014 Q1 | 335.39 Million INR | 389.78% |
2014 FY | 1.19 Billion INR | -7.09% |
2014 Q4 | -10.72 Million INR | -101.94% |
2013 Q3 | 376.77 Million INR | -6.82% |
2013 Q4 | 68.47 Million INR | -81.82% |
2013 Q2 | 404.36 Million INR | -11.69% |
2013 FY | 1.28 Billion INR | 9.75% |
2013 Q1 | 457.91 Million INR | 206.61% |
2012 Q4 | -429.54 Million INR | -189.67% |
2012 Q3 | 479.01 Million INR | 12.69% |
2012 FY | 1.17 Billion INR | 0.0% |
2012 Q1 | - INR | 0.0% |
2012 Q2 | 425.06 Million INR | 0.0% |
2010 FY | 866.44 Million INR | 21.62% |
2009 FY | 712.43 Million INR | 13.25% |
2008 FY | 629.07 Million INR | 2.53% |
2007 FY | 613.57 Million INR | 26.99% |
2006 FY | 483.16 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.035% |
Hester Biosciences Limited | 908.84 Million INR | -4.151% |
Aarti Drugs Limited | 1.16 Billion INR | 18.922% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 69.211% |
Albert David Limited | 1.02 Billion INR | 7.755% |
Alembic Limited | 872.45 Million INR | -8.494% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.117% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -107.77% |
Bajaj HealthCare Limited | 985.34 Million INR | 3.935% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -13779.282% |
Brooks Laboratories Limited | 51.18 Million INR | -1749.486% |
Eris Lifesciences Limited | 4.94 Billion INR | 80.85% |
FDC Limited | 3.49 Billion INR | 72.953% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.868% |
Gufic Biosciences Limited | 1.18 Billion INR | 20.228% |
Hikal Limited | 4.46 Billion INR | 78.795% |
Innova Captab Limited | 931.03 Million INR | -1.669% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 56.994% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -115.84% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.451% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 11.881% |
Lupin Limited | 125.09 Billion INR | 99.243% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -483.479% |
Medico Remedies Limited | 59.67 Million INR | -1486.204% |
Morepen Laboratories Limited | 1.98 Billion INR | 52.373% |
Nectar Lifesciences Limited | 932.7 Million INR | -1.487% |
Orchid Pharma Limited | 800.77 Million INR | -18.207% |
Procter & Gamble Health Limited | 2.99 Billion INR | 68.399% |
RPG Life Sciences Limited | 1.63 Billion INR | 42.124% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -129.511% |
Sigachi Industries Limited | 579.88 Million INR | -63.233% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 62.939% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 32.522% |
Themis Medicare Limited | 1.12 Billion INR | 15.92% |
Unichem Laboratories Limited | 6.72 Billion INR | 85.926% |
Vaishali Pharma Limited | 84.02 Million INR | -1026.477% |
Wanbury Limited | 978.96 Million INR | 3.31% |
Windlas Biotech Limited | 1 Billion INR | 5.956% |
ZIM Laboratories Limited | 1.01 Billion INR | 6.563% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 55.439% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.015% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.386% |
Venus Remedies Limited | 1.91 Billion INR | 50.604% |
Sakar Healthcare Limited | 204.07 Million INR | -363.824% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.299% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.32% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 61.732% |
Mankind Pharma Limited | 29.27 Billion INR | 96.766% |
Sequent Scientific Limited | 2.9 Billion INR | 67.38% |
Laurus Labs Limited | 11.9 Billion INR | 92.052% |
Neuland Laboratories Limited | 2.92 Billion INR | 67.691% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.601% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.984% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.244% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 54.797% |
Wockhardt Limited | 8.48 Billion INR | 88.838% |
Bal Pharma Limited | 555.62 Million INR | -70.36% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.013% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 33.304% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1523.948% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 56.47% |
Shilpa Medicare Limited | 3.33 Billion INR | 71.61% |
Valiant Laboratories Limited | 138.02 Million INR | -585.774% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.893% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6559.868% |
Granules India Limited | 10.31 Billion INR | 90.821% |
Medicamen Biotech Limited | 335.16 Million INR | -182.417% |
Syncom Formulations (India) Limited | 345.63 Million INR | -173.865% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.513% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.581% |
NATCO Pharma Limited | 10.05 Billion INR | 90.589% |
Suven Life Sciences Limited | 109.75 Million INR | -762.476% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1950.799% |
Strides Pharma Science Limited | 9.16 Billion INR | 89.669% |
Indoco Remedies Limited | 12.06 Billion INR | 92.152% |
Alpa Laboratories Limited | 127.38 Million INR | -643.105% |
Lasa Supergenerics Limited | 291.17 Million INR | -225.086% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 69.235% |